Meriva® highly bioavailable turmeric-phytosome
Helps relieve joint inflammation and associated symptoms such as joint pain when used in conjunction with conventional treatment
Provides antioxidants for the maintenance of good health
Clinically studied for enhanced absorption
Made with vegan ingredients
CurcumaSorb provides the patented Meriva® curcumin-phosphatidylcholine complex for enhanced absorption and bioavailability. The proprietary phytosome technology combines curcumin and phosphatidylcholine in a 1:2 ratio, promoting resistance to degradation in the digestive tract and efficient absorption across membranes. This produces significantly higher peak plasma concentrations and larger area under concentration-time curves (AUC). In a single-dose pharmacokinetic animal study, plasma curcumin levels were 20 times greater with Meriva® than standard curcumin. A preliminary human pharmacokinetic study demonstrated that elevations in plasma curcumin from 450 mg Meriva® were similar to values obtained from 4,000 mg of a standard curcumin extract. The efficacy of a low dose was demonstrated in a three-month clinical trial, in which 200 mg curcuminoids from Meriva® per day helped relieve joint inflammation and provided significant benefit in joint comfort, mobility and quality of life when used in conjunction with conventional treatment.
Medicinal Ingredients(per capsule): Meriva® 250 mg Providing 150 mg Curcuminoids-Phoshphatidylcholine Complex standardized to contain 30% curcuminoids (from turmeric (Curcuma longa) rhizome and sunflower (Helianthus annuus) seed). Non-Medicinal Ingredients: Hypoallergenic plant cellulose, vegetarian capsule (hypromellose, water).
Recommended Use: Helps relieve joint inflammation and associated symptoms such as joint pain when used in conjunction with conventional treatment. Provides antioxidants for the maintenance of good health. Recommended Dose: Adults: Take 2 capsules 2-3 times daily, or as directed by a healthcare practitioner.